These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9347498)

  • 21. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.
    Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR
    Pediatrics; 1999 Apr; 103(4):e44. PubMed ID: 10103336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thalidomide neuropathy: role of F-wave monitoring.
    Rao DG; Kane NM; Oware A
    Muscle Nerve; 2000 Aug; 23(8):1301-2. PubMed ID: 10918274
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide for the treatment of chronic graft-versus-host disease.
    Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR
    N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
    Ueno NT; Rondón G; Mirza NQ; Geisler DK; Anderlini P; Giralt SA; Andersson BS; Claxton DF; Gajewski JL; Khouri IF; Körbling M; Mehra RC; Przepiorka D; Rahman Z; Samuels BI; van Besien K; Hortobagyi GN; Champlin RE
    J Clin Oncol; 1998 Mar; 16(3):986-93. PubMed ID: 9508181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
    Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
    Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy.
    Kocer B; Sucak G; Kuruoglu R; Aki Z; Haznedar R; Erdogmus NI
    Acta Neurol Belg; 2009 Jun; 109(2):120-6. PubMed ID: 19681443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Potential side effects of thalidomide].
    Rev Prat; 2006 Jan; 56(1):52. PubMed ID: 16548249
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
    Fujii N; Ikeda K; Koyama M; Aoyama K; Masunari T; Kondo E; Matsuzaki T; Mizobuchi S; Hiraki A; Teshima T; Shinagawa K; Ishimaru F; Tanimoto M
    Int J Hematol; 2006 Jun; 83(5):459-61. PubMed ID: 16787880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical thalidomide gel in oral chronic GVHD and role of in situ cytokine expression in monitoring biological activity.
    St John L; Gordon SM; Childs R; Marquesen M; Pavletic SZ; Wu TX; Cozzarelli T; Schroeder E; Saria MG; Fall-Dickson JM
    Bone Marrow Transplant; 2013 Apr; 48(4):610-1. PubMed ID: 23000649
    [No Abstract]   [Full Text] [Related]  

  • 32. Paresthesias and sensory neuropathy due to 1,1,1-trichloroethane.
    House RA; Liss GM; Wills MC; Holness DL
    J Occup Environ Med; 1996 Feb; 38(2):123-4. PubMed ID: 8673514
    [No Abstract]   [Full Text] [Related]  

  • 33. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.
    Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M;
    Lancet; 2010 Dec; 376(9758):2075-85. PubMed ID: 21146205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide in 42 patients with prurigo nodularis Hyde.
    Andersen TP; Fogh K
    Dermatology; 2011; 223(2):107-12. PubMed ID: 21952556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus.
    Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A
    Neurology; 2004 Jun; 62(12):2288-90. PubMed ID: 15210897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
    Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
    Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.
    de Souza JA; Davis ML; Rondon G; Cheng YC; Jones RB; Champlin RE; Ueno NT
    Bone Marrow Transplant; 2009 Jul; 44(2):81-7. PubMed ID: 19448681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thalidomide-induced sensory neuropaty in patients with multiple myeloma].
    Bilińska M; Usnarska-Zubkiewicz L; Szymczyk M; Noga L; Potoczek S; Kuliczkowski K; Podemski R
    Pol Merkur Lekarski; 2011 Aug; 31(182):86-91. PubMed ID: 21936343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.
    Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW
    Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.